FDA Inspection 1195097 — Wavelength Enterprises Ltd.
The FDA completed an inspection of Wavelength Enterprises Ltd. on Dec 14, 2022 in Beer Sheva. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beer Sheva (Israel)